Based on this natural resistance, cancer patients with an active HIV-1 infection received allogeneic hematopoietic stem cell transplantation (HSCT ) from donors homozygous for CCR5 Δ32 (13). This evidence concerns the gene CCR5 and HIV-1 infection.